BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 16476118)

  • 21. The development of a sleep disorder screening program in Australian community pharmacies.
    Tran A; Fuller JM; Wong KK; Krass I; Grunstein R; Saini B
    Pharm World Sci; 2009 Aug; 31(4):473-480. PubMed ID: 19462256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prevalence of sleep disorders in an employed Swiss population: results of a questionnaire survey].
    Schmitt BE; Gugger M; Augustiny K; Bassetti C; Radanov BP
    Schweiz Med Wochenschr; 2000 May; 130(21):772-8. PubMed ID: 10904985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and patient awareness of selected potential drug interactions with self-medication.
    Indermitte J; Reber D; Beutler M; Bruppacher R; Hersberger KE
    J Clin Pharm Ther; 2007 Apr; 32(2):149-59. PubMed ID: 17381665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sleep and wakefulness disturbances in Swiss pharmacy customers.
    Schwegler K; Klaghofer R; Nirkko AC; Mathis J; Hersberger KE; Bloch KE
    Swiss Med Wkly; 2006 Mar; 136(9-10):149-54. PubMed ID: 16633960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sleep disturbances in the elderly residing in assisted living: findings from the Maryland Assisted Living Study.
    Rao V; Spiro JR; Samus QM; Rosenblatt A; Steele C; Baker A; Harper M; Brandt J; Mayer L; Rabins PV; Lyketsos CG
    Int J Geriatr Psychiatry; 2005 Oct; 20(10):956-66. PubMed ID: 16163747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sleep disorders screening, sleep health awareness, and patient follow-up by community pharmacists in Australia.
    Fuller JM; Wong KK; Krass I; Grunstein R; Saini B
    Patient Educ Couns; 2011 Jun; 83(3):325-35. PubMed ID: 21640541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for sleep disorders in community pharmacies--evaluation of a campaign in Switzerland.
    Hersberger KE; Renggli VP; Nirkko AC; Mathis J; Schwegler K; Bloch KE
    J Clin Pharm Ther; 2006 Feb; 31(1):35-41. PubMed ID: 16476118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmaceutical care in community pharmacies: practice and research in Sweden.
    Westerlund LT; Björk HT
    Ann Pharmacother; 2006 Jun; 40(6):1162-9. PubMed ID: 16735653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is daytime sleepiness a neglected problem in patients with restless legs syndrome?
    Fulda S; Wetter TC
    Mov Disord; 2007; 22 Suppl 18():S409-13. PubMed ID: 17588232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Objective measures of sleepiness and wakefulness: application to the real world?
    Wise MS
    J Clin Neurophysiol; 2006 Feb; 23(1):39-49. PubMed ID: 16514350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recognizing problem sleepiness in your patients. National Center on Sleep Disorders Research Working Group.
    Am Fam Physician; 1999 Feb; 59(4):937-44. PubMed ID: 10068715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical assessment of the sleep disordered patient.
    Linley LA
    Respir Care Clin N Am; 2005 Dec; 11(4):597-603. PubMed ID: 16303591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Outline and overview of sleep disorders].
    Ohta T
    Ryoikibetsu Shokogun Shirizu; 2003; (39):41-7. PubMed ID: 14503204
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.